蛋白质是生物功能的主要载体，如果能像基因测序一样直接破译蛋白的一级结构，对了解生命活动的分子机制具有重大意义。Rapid Novor一直致力于无需基因序列的蛋白从头测序技术，是全球首个提供单克隆抗体自动化测序服务的公司。目前Rapd Novor拥有全球最大的蛋白测序质谱平台，是蛋白从头测序技术的领跑者。RapdNovor的蛋白从头测序技术已被应用于多发性骨髓瘤MRD监测，可以直接对人血清高浓度单克隆免疫球蛋白进行测序，并获得美国CLIA临床认证。上海快序生物科技有限公司是加拿大Rapid Novor 的中国公司。快序生物在中国提供的服务包括:抗体测序，抗体发现，肿瘤新抗原鉴定服务等。
Rapid Novor Shanghai Kuaixu Biotechnologies Co., Ltd. )has the world's leading de novo protein sequencing technologyand is commited to the applicationof this technolosy in the medical field. De novo sequencing is a technique that does not rely on existing DNA or protein database information and directlydetermines the amino acid sequence of proteins. Based on this technology. Rapid Novor(Kuaikxu) has established a new platform for antibody discovery andneoantigen identification. The antibody discovery platform can directly sequence antibody proteins in the serum ofimmunized animals or humans to obtainnatural antibody sequences, thereby significantly shortening the cycle of antibody drug development. However, drect sequencing of the MHC-bound peptidesegmentto obtain the actualpresented neoantigen sequence completely changes the previous discovery mode of neoantigens, which was mainly predicted bythe gene sequencing and algorthm. Rapid Novor (Kuaixu) has always been commited to developing the next generation of protein sequencing technology todecode the immune system and benefit human health.
官网链接：https://www.kuaixu.com/